Supplementary Table 9 from EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell–Dependent Manner
Year: 2026
Type: supplementary-materials
Abstract: Hallmark pathways enriched in ID8-R cells treated with combinatory UNC0642/Olaparib compared to Olaparib alone.
Authors: Lily L. Nguyen, Zachary L. Watson, Raquel Ortega, Elizabeth R. Woodruff, Kimberly R. Jordan, Ritsuko Iwanaga, Tomomi M. Yamamoto, Courtney A. Bailey, Francis To, Shujian Lin, Fabian R. Villagomez, Abigail D. Jeong, Saketh R. Guntupalli, Kian Behbakht, Veronica Gibaja, Nausica Arnoult, Edward B. Chuong, Benjamin G. Bitler
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7165033124
Cites:
Cited by:
Related to:
